Giant cell hepatitis and autoimmune hemolytic anemia successfully treated with rituximab.
Miloh
Tamir
T
Recanati Transplant Institute, Mt. Sinai School of Medicine, New York, NY 10029, USA. tamir.miloh@mssm.edu
Manwani
Deepa
D
Morotti
Raffaella
R
Sukru
Emre
E
Shneider
Benjamin
B
Kerkar
Nanda
N
D000744:Anemia, Hemolytic, Autoimmune / Q000188:drug therapy* / Q000453:epidemiology; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D015897:Comorbidity; D015726:Giant Cells; D006505:Hepatitis / Q000188:drug therapy* / Q000453:epidemiology; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D007223:Infant; D008297:Male; D000069283:Rituximab; D016896:Treatment Outcome
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D007155:Immunologic Factors; D000069283:Rituximab